Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.82 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.60 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA4 | P22748 | 3/20 | 0.60 |
| ▸ | CA7 | P43166 | 3/20 | 0.60 |
| ▸ | CA9 | Q16790 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL2777 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL27618507 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL2561870 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL30100313 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL8398555 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL7897915 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL11323294 | 1.00 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL6336453 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL6383293 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 | |
| Phthalic Acid SCHEMBL1896598 | 0.97 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250215321-A1 | COMPOSITIONS AND METHODS FOR REDUCING DELETERIOUS ATMOSPHERIC GAS EMISSIONS FROM FLOODED ECOSYSTEMS | Arkea Bio Corp. | 2025-07-03 | — | — | US | claimed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | claimed |
| EP-4554616-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024252420-A1 | TRIPLE RELEASE TABLET-IN-TABLET FORMULATION | AKUMS DRUGS & PHARMACEUTICALS LIMITED (IN) | 2024-12-12 | — | — | WO | claimed |
| US-12084610-B2 | Compositions and methods for reducing deleterious atmospheric gas emissions from flooded ecosystems | Arkea Bio Corp. (US) | 2024-09-10 | — | — | US | claimed |
| WO-2024015366-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2024-01-18 | — | — | WO | claimed |
| WO-2024006531-A1 | COMPOSITIONS AND METHODS FOR REDUCING DELETERIOUS ATMOSPHERIC GAS EMISSIONS FROM FLOODED ECOSYSTEMS | Arkea Bio Corp. (US) | 2024-01-04 | — | — | WO | claimed |
| US-20240002726-A1 | COMPOSITIONS AND METHODS FOR REDUCING DELETERIOUS ATMOSPHERIC GAS EMISSIONS FROM FLOODED ECOSYSTEMS | Arkea Bio Corp. | 2024-01-04 | — | — | US | claimed |
| EP-3662054-B1 | A THREE-DIMENSIONAL HYDROGEL SCAFFOLD FOR CELL CULTURING AND A METHOD FOR THE PRODUCTION THEREOF | UNIV DEGLI STUDI GENOVA (IT) | 2022-08-03 | — | — | EP | claimed |
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250215321-A1 | COMPOSITIONS AND METHODS FOR REDUCING DELETERIOUS ATMOSPHERIC GAS EMISSIONS FROM FLOODED ECOSYSTEMS | Arkea Bio Corp. | 2025-07-03 | — | — | US | disclosed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-3975996-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HBV | Assembly Biosciences, Inc. (US) | 2022-04-06 | — | — | EP | disclosed |
| EP-3962461-A1 | NEW DELIVERY SYSTEM FOR FAT SOLUBLE VITAMINS | DSM IP Assets B.V. (NL) | 2022-03-09 | — | — | EP | disclosed |
| EP-3962463-A1 | NEW DELIVERY SYSTEM FOR SPECIFIC WATER-SOLUBLE VITAMINS | DSM IP Assets B.V. (NL) | 2022-03-09 | — | — | EP | disclosed |
| EP-3962462-A1 | NEW DELIVERY SYSTEM FOR POLYUNSATURATED FATTY ACIDS | DSM IP Assets B.V. (NL) | 2022-03-09 | — | — | EP | disclosed |
| EP-3941441-A1 | PROLONGED RELEASE FORMULATION COMPRISING TACROLIMUS | Pharmathen S.A. (GR) | 2022-01-26 | — | — | EP | disclosed |